Alexandra Nicole Carey, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fat Emulsions, Intravenous | 5 | 2022 | 321 | 1.070 |
Why?
|
| Fish Oils | 4 | 2022 | 470 | 0.920 |
Why?
|
| Parenteral Nutrition, Home | 5 | 2023 | 35 | 0.890 |
Why?
|
| Short Bowel Syndrome | 6 | 2023 | 345 | 0.860 |
Why?
|
| Parenteral Nutrition | 4 | 2023 | 650 | 0.680 |
Why?
|
| Fatty Acids, Essential | 1 | 2018 | 95 | 0.620 |
Why?
|
| Cholestasis | 2 | 2019 | 378 | 0.610 |
Why?
|
| Vitamin E Deficiency | 1 | 2017 | 32 | 0.590 |
Why?
|
| Anemia, Hemolytic | 1 | 2017 | 168 | 0.540 |
Why?
|
| Intestinal Diseases | 3 | 2023 | 530 | 0.420 |
Why?
|
| Postoperative Care | 1 | 2018 | 1486 | 0.400 |
Why?
|
| Intestinal Volvulus | 2 | 2023 | 65 | 0.380 |
Why?
|
| Catheter-Related Infections | 3 | 2023 | 252 | 0.340 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 1889 | 0.320 |
Why?
|
| Liver | 2 | 2018 | 7474 | 0.250 |
Why?
|
| Digestive System Abnormalities | 1 | 2023 | 52 | 0.230 |
Why?
|
| Plethysmography | 1 | 2023 | 180 | 0.220 |
Why?
|
| Pediatrics | 2 | 2019 | 3475 | 0.220 |
Why?
|
| Acidosis, Lactic | 1 | 2023 | 142 | 0.210 |
Why?
|
| Acidosis | 1 | 2023 | 270 | 0.200 |
Why?
|
| Soybean Oil | 2 | 2021 | 133 | 0.190 |
Why?
|
| Infant | 8 | 2023 | 35136 | 0.180 |
Why?
|
| Electric Impedance | 1 | 2023 | 729 | 0.170 |
Why?
|
| Intestine, Small | 2 | 2023 | 1241 | 0.170 |
Why?
|
| Catheterization, Central Venous | 1 | 2023 | 514 | 0.160 |
Why?
|
| Gastroschisis | 1 | 2019 | 97 | 0.160 |
Why?
|
| Gastroenterology | 1 | 2023 | 536 | 0.150 |
Why?
|
| Absorptiometry, Photon | 1 | 2023 | 1725 | 0.150 |
Why?
|
| Bile Ducts | 1 | 2018 | 284 | 0.150 |
Why?
|
| Child | 14 | 2023 | 77709 | 0.140 |
Why?
|
| Phosphatidylethanolamines | 1 | 2017 | 134 | 0.140 |
Why?
|
| Biliary Atresia | 1 | 2017 | 73 | 0.140 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2018 | 159 | 0.140 |
Why?
|
| Enteral Nutrition | 1 | 2022 | 763 | 0.140 |
Why?
|
| Bacteremia | 1 | 2023 | 962 | 0.140 |
Why?
|
| Medication Reconciliation | 1 | 2017 | 151 | 0.130 |
Why?
|
| Pruritus | 1 | 2019 | 361 | 0.130 |
Why?
|
| Phosphatidylcholines | 1 | 2017 | 411 | 0.130 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2017 | 223 | 0.130 |
Why?
|
| Intestines | 3 | 2019 | 1924 | 0.130 |
Why?
|
| Colitis | 1 | 2023 | 1170 | 0.120 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2019 | 388 | 0.120 |
Why?
|
| Body Composition | 1 | 2023 | 2401 | 0.120 |
Why?
|
| Fatty Acids | 1 | 2022 | 1809 | 0.120 |
Why?
|
| Neonatal Screening | 1 | 2017 | 591 | 0.110 |
Why?
|
| Infant, Newborn | 4 | 2022 | 25625 | 0.110 |
Why?
|
| Vitamin E | 1 | 2017 | 869 | 0.110 |
Why?
|
| Child, Preschool | 7 | 2023 | 41006 | 0.100 |
Why?
|
| Animals, Newborn | 1 | 2017 | 2726 | 0.100 |
Why?
|
| Interleukin-2 | 1 | 2018 | 1904 | 0.100 |
Why?
|
| Adipose Tissue | 1 | 2023 | 3279 | 0.100 |
Why?
|
| Medication Errors | 1 | 2017 | 798 | 0.100 |
Why?
|
| Prospective Studies | 4 | 2023 | 53288 | 0.090 |
Why?
|
| Infant, Premature, Diseases | 1 | 2017 | 706 | 0.090 |
Why?
|
| Heterozygote | 1 | 2017 | 2804 | 0.090 |
Why?
|
| Curriculum | 2 | 2023 | 3605 | 0.090 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2017 | 1836 | 0.090 |
Why?
|
| Venous Thromboembolism | 1 | 2022 | 1671 | 0.090 |
Why?
|
| Mass Spectrometry | 1 | 2017 | 2203 | 0.090 |
Why?
|
| Humans | 22 | 2023 | 744343 | 0.080 |
Why?
|
| History, 20th Century | 1 | 2017 | 2740 | 0.080 |
Why?
|
| Liver Cirrhosis | 1 | 2019 | 1863 | 0.080 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2023 | 2425 | 0.080 |
Why?
|
| Caregivers | 1 | 2019 | 2094 | 0.070 |
Why?
|
| Infant, Premature | 1 | 2017 | 2044 | 0.070 |
Why?
|
| Patient Discharge | 1 | 2019 | 3313 | 0.070 |
Why?
|
| Homeostasis | 1 | 2017 | 3340 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 19905 | 0.060 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2018 | 2988 | 0.060 |
Why?
|
| Female | 11 | 2023 | 380194 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 7181 | 0.060 |
Why?
|
| Glucagon-Like Peptide 2 | 1 | 2023 | 50 | 0.060 |
Why?
|
| Quality Improvement | 1 | 2018 | 3749 | 0.050 |
Why?
|
| Retrospective Studies | 8 | 2023 | 77449 | 0.050 |
Why?
|
| Inflammation | 2 | 2023 | 10638 | 0.050 |
Why?
|
| Telemedicine | 1 | 2018 | 2872 | 0.050 |
Why?
|
| North America | 1 | 2023 | 1249 | 0.050 |
Why?
|
| Phenotype | 1 | 2017 | 16365 | 0.040 |
Why?
|
| Animals | 3 | 2022 | 168757 | 0.040 |
Why?
|
| Glucose | 2 | 2023 | 4397 | 0.040 |
Why?
|
| Microvilli | 1 | 2019 | 241 | 0.040 |
Why?
|
| Lactic Acid | 1 | 2023 | 1133 | 0.040 |
Why?
|
| Mucolipidoses | 1 | 2019 | 82 | 0.040 |
Why?
|
| Malabsorption Syndromes | 1 | 2019 | 135 | 0.040 |
Why?
|
| Male | 10 | 2023 | 350118 | 0.040 |
Why?
|
| Rehabilitation Centers | 1 | 2019 | 254 | 0.040 |
Why?
|
| Electrolytes | 1 | 2017 | 282 | 0.040 |
Why?
|
| Ethanol | 1 | 2023 | 1342 | 0.040 |
Why?
|
| Blood Coagulation | 1 | 2022 | 1127 | 0.040 |
Why?
|
| Drug Compounding | 1 | 2017 | 242 | 0.030 |
Why?
|
| Computer Security | 1 | 2018 | 262 | 0.030 |
Why?
|
| Videoconferencing | 1 | 2018 | 195 | 0.030 |
Why?
|
| Heparin | 1 | 2023 | 1637 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2018 | 767 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2023 | 21746 | 0.030 |
Why?
|
| Fellowships and Scholarships | 1 | 2023 | 1076 | 0.030 |
Why?
|
| Micronutrients | 1 | 2017 | 375 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2018 | 2505 | 0.030 |
Why?
|
| Mice | 2 | 2018 | 81183 | 0.030 |
Why?
|
| Remission Induction | 1 | 2019 | 2386 | 0.030 |
Why?
|
| Triglycerides | 1 | 2021 | 2454 | 0.030 |
Why?
|
| Mutation | 1 | 2017 | 29786 | 0.030 |
Why?
|
| Fibrosis | 1 | 2018 | 2029 | 0.020 |
Why?
|
| Education, Medical, Graduate | 1 | 2023 | 2291 | 0.020 |
Why?
|
| Amino Acids | 1 | 2017 | 1736 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 1678 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2023 | 8324 | 0.020 |
Why?
|
| Adolescent | 3 | 2023 | 85781 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 6386 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2019 | 2278 | 0.020 |
Why?
|
| Adult | 4 | 2023 | 214055 | 0.020 |
Why?
|
| Sleep | 1 | 2023 | 4623 | 0.020 |
Why?
|
| Incidence | 1 | 2022 | 20947 | 0.010 |
Why?
|
| Patient Readmission | 1 | 2018 | 3114 | 0.010 |
Why?
|
| Pandemics | 1 | 2023 | 8388 | 0.010 |
Why?
|
| Quality of Life | 1 | 2023 | 12804 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2023 | 15295 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 18029 | 0.010 |
Why?
|
| Prognosis | 1 | 2019 | 29063 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 39050 | 0.010 |
Why?
|
| Time Factors | 1 | 2019 | 40075 | 0.010 |
Why?
|
| Young Adult | 1 | 2022 | 56430 | 0.010 |
Why?
|
| Risk Factors | 1 | 2022 | 72290 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2017 | 40561 | 0.010 |
Why?
|
| Middle Aged | 1 | 2023 | 213383 | 0.010 |
Why?
|